TMR’s report on the global periodontal therapeutics market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period 2019–2027. The report provides the revenue of the global periodontal therapeutics market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global periodontal therapeutics market during the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global periodontal therapeutics market.
Request Brochure for Report –
Global Periodontal Therapeutics Market Witness Most Promising Rise in Demand:
According to Transparency Market Research’s latest report on the global periodontal therapeutics market for the historical period 2017–2018 and forecast period 2019–2027, rise in reported cases of periodontitis, Increase in prevalence of diabetes, rise in global geriatric population and surge in awareness about oral health are projected to drive the global periodontal therapeutics market
According to the report, the global periodontal therapeutics market was valued at US$ 536.8 Mn in 2018 and is anticipated to expand at a CAGR of 8.8% from 2019 to 2027
Request for Analysis of COVID19 Impact on Periodontal Therapeutics Market –
Periodontal diseases comprising gingivitis and periodontitis are prevalent both in developing and developed countries and affect around 20% to 50% of the global population
According to the Global Burden of Disease Study (GBD, 1990–2010), severe periodontitis is the 6th most prevalent disease worldwide, and has an overall prevalence of 11.2% and an estimated 743 million people worldwide are affected by it. The global burden of periodontal diseases has increased by as much as 57.3% from 1990 to 2010.
Periodontitis is one of the major causes of tooth loss in adult population across the world. These individuals are at risk of edentulism, masticatory dysfunction, and multiple tooth loss which in turn affects nutrition, self-esteem, and quality of life as well as imposes high health care and significant socio-economic costs.
Key Players of Periodontal Therapeutics Market Report:
This report profiles major players in the global periodontal therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
Key players operating in the global periodontal therapeutics market include: Den-Mat Holdings, LLC, Valeant Pharmaceuticals International, Inc., Dexcel Pharma, 3M Company, Oral Science, Kaken Pharmaceutical Co., Ltd.
Buy Periodontal Therapeutics Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=24614<ype=S
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453